Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival ; volume:15 ; number:1 ; day:22 ; month:9 ; year:2015 ; pages:1-12 ; date:12.2015
BMC cancer ; 15, Heft 1 (22.9.2015), 1-12, 12.2015
- Creator
-
Paiva, Tadeu Ferreira
- Contributor
-
de Jesus, Victor Hugo Fonseca
Marques, Raul Amorim
da Costa, Alexandre Andre Balieiro Anastacio
de Macedo, Mariana Petaccia
Peresi, Patricia Maria
Damascena, Aline
Rossi, Benedito Mauro
Begnami, Maria Dirlei
de Lima, Vladmir Cláudio Cordeiro
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1648-4
- URN
-
urn:nbn:de:1111-2016110618014
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Paiva, Tadeu Ferreira
- de Jesus, Victor Hugo Fonseca
- Marques, Raul Amorim
- da Costa, Alexandre Andre Balieiro Anastacio
- de Macedo, Mariana Petaccia
- Peresi, Patricia Maria
- Damascena, Aline
- Rossi, Benedito Mauro
- Begnami, Maria Dirlei
- de Lima, Vladmir Cláudio Cordeiro
- SpringerLink (Online service)
Other Objects (12)
Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis
Identifizierung potentieller Notch1-Zielgene
Co-delivery of Liposomal Ketoconazole and Bevacizumab for Synergistical Inhibition of Angiogenesis Against Endometrial Cancer
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
Multiple mechanisms of NOTCH1 activation in chronic lymphocytic leukemia: NOTCH1 mutations and beyond
Optogenetic control of NOTCH1 signaling
Targetable NOTCH1 rearrangements in reninoma
Analysen zum Kernimport von Notch1
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway
Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis
Identifizierung potentieller Notch1-Zielgene
Co-delivery of Liposomal Ketoconazole and Bevacizumab for Synergistical Inhibition of Angiogenesis Against Endometrial Cancer
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
Multiple mechanisms of NOTCH1 activation in chronic lymphocytic leukemia: NOTCH1 mutations and beyond
Optogenetic control of NOTCH1 signaling
Targetable NOTCH1 rearrangements in reninoma
Analysen zum Kernimport von Notch1
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway
Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis
Identifizierung potentieller Notch1-Zielgene
Co-delivery of Liposomal Ketoconazole and Bevacizumab for Synergistical Inhibition of Angiogenesis Against Endometrial Cancer
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
Multiple mechanisms of NOTCH1 activation in chronic lymphocytic leukemia: NOTCH1 mutations and beyond
Optogenetic control of NOTCH1 signaling
Targetable NOTCH1 rearrangements in reninoma
Analysen zum Kernimport von Notch1
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab